Ivermectin shows ‘antiviral effect’ against COVID, Japanese company says

Petition updateDemand FDA Approval for Emergency Use of Ivermectin for Covid 19 TreatmentIvermectin shows ‘antiviral effect’ against COVID, Japanese company says

Diana ZFair Lawn, NJ, United States

Jan 31, 2022

TOKYO, Jan 31 (Reuters) - Japanese trading and pharmaceuticals company Kowa Co Ltd (7807.T) on Monday said that anti-parasite drug ivermectin showed an "antiviral effect" against Omicron and other coronavirus variants in joint non-clinical research.

Support now

Sign this petition

Copy link

Facebook

Nextdoor

Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in Covid Treatments

Military documents about covid gain of function